Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-28 @ 10:34 PM
Study NCT ID:
NCT06771934
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-13
First Post:
2025-01-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma
Sponsor:
Qianfoshan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-07
First Submit QC Date:
None
Study First Post Date:
2025-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-07
Last Update Post Date:
2025-01-13
Last Update Post Date Type:
ACTUAL